ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $83,421 | +30.3% | 5,240 | +33.1% | 0.00% | 0.0% |
| Q3 2022 | $64,000 | +68.4% | 3,937 | +45.3% | 0.00% | +100.0% |
| Q2 2022 | $38,000 | +153.3% | 2,709 | +328.6% | 0.00% | – |
| Q1 2022 | $15,000 | -72.7% | 632 | -70.4% | 0.00% | -100.0% |
| Q1 2021 | $55,000 | -92.3% | 2,133 | -83.9% | 0.00% | -93.9% |
| Q4 2020 | $710,000 | +5.5% | 13,277 | -18.7% | 0.03% | -13.2% |
| Q3 2020 | $673,000 | +1822.9% | 16,325 | +2139.4% | 0.04% | +533.3% |
| Q2 2020 | $35,000 | -5.4% | 729 | -17.6% | 0.01% | -70.0% |
| Q1 2020 | $37,000 | – | 885 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |